carbapenems has been researched along with trimethoprim, sulfamethoxazole drug combination in 32 studies
Studies (carbapenems) | Trials (carbapenems) | Recent Studies (post-2010) (carbapenems) | Studies (trimethoprim, sulfamethoxazole drug combination) | Trials (trimethoprim, sulfamethoxazole drug combination) | Recent Studies (post-2010) (trimethoprim, sulfamethoxazole drug combination) |
---|---|---|---|---|---|
7,355 | 147 | 5,277 | 7,527 | 875 | 2,260 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (3.13) | 18.2507 |
2000's | 3 (9.38) | 29.6817 |
2010's | 19 (59.38) | 24.3611 |
2020's | 9 (28.13) | 2.80 |
Authors | Studies |
---|---|
Suppola, JP; Vaara, M; Valtonen, VV; Volin, L | 1 |
Duff, P | 1 |
Arroyo, E; Figueroa, J; González, G; Maldonado, G; Meléndez, B; Ramírez-Ronda, CH; Rodríguez-Julbe, MC; Saavedra, S | 1 |
Gospodarek, E; Jachna-Sawicka, K | 1 |
Ben-Ami, R; Bishara, J; Block, C; Chazan, B; Chowers, M; Dan, M; Giladi, M; Kassis, I; Keller, N; Kontoyiannis, DP; Krieger, M; Olshtain-Pops, K; Oren, I; Potasman, I; Shalit, I; Weber, G; Weinberger, M; Wiener-Well, Y; Zimhony, O | 1 |
Kemper, AL; Young, DC; Zobell, JT | 1 |
Apter, S; Eviatar, T; Grossman, E; Hoffman, C; Keller, N; Rosman, Y; Thaler, M | 1 |
Kanafani, ZA; Kanj, SS; Kmeid, JG; Youssef, MM | 1 |
Brun, V; Gautier, P; Henaux, PL; Kayal, S; Kerjouan, M; Le Mouel, M; Morin, MP; Patrat-Delon, S; Piau, C; Rodriguez-Nava, V | 1 |
Kollef, MH; Shorr, AF; Zilberberg, MD | 1 |
Abbo, LM; Aragon, L; Beduschi, T; Camargo, JF; Cantón, R; Morris, MI; Pérez-Cardona, A; Prado, CE; Simkins, J; Tekin, A | 1 |
Correia, A; Henriques, IS; Tacão, M | 1 |
Çöl, A; Dedeić-Ljubović, A; Hukic, M; Salimović-Bešić, I | 1 |
Askin, G; Chen, L; Cohen, N; Gedrimaite, Z; Kreiswirth, BN; Ma, KC; Satlin, MJ; Seo, SK; Soave, R; Walsh, TJ | 1 |
Kraniotaki, E; Nepka, M; Perivolioti, E; Politi, L; Pournaras, S; Tsakris, A | 1 |
Cho, SY; Chung, DR; Ha, YE; Huh, K; Kang, CI; Kim, SH; Lee, NY; Peck, KR; Seok, H; Song, JH | 1 |
Abu Sin, M; Claus, H; Eckmanns, T; Feig, M; Koppe, U; Kroll, LE; Noll, I; Schneider, M; von Laer, A | 1 |
Guo, Q; Guo, Y; Li, D; Su, J; Xu, X; Zheng, Y | 1 |
Chan, EW; Chen, S; Li, R; Ye, L; Zheng, Z | 1 |
Kauffman, CA; Leavens, J; Miceli, MH; Steinbrink, J | 1 |
Hefzy, EM; Khalil, MAF; Moawad, SS | 1 |
Abdelgani, S; Amir-Ronen, R; Geffen, Y; Liron, Y; Ohanyan, A; Paul, M; Raz-Pasteur, A | 1 |
Akkoyunlu, Y; Aslan, T; Daskaya, H; Durdu, B; Hakyemez, IN; Meric Koc, M; Sumbul Gultepe, B | 1 |
Demir, M; Kazanasmaz, H | 1 |
Cao, Y; Chen, L; Chen, T; Liu, H; Wang, L; Yang, C; Zhou, W | 1 |
Gao, E; Guo, J; Jiang, L; Li, S; Liu, Z; Xu, S | 1 |
Deligios, M; Fiamma, M; Paglietti, B; Rubino, S; Sacarlal, J; Santona, A; Simbine, SE; Sumbana, JJ; Taviani, E; Zimba, T | 1 |
Armaki, MT; Gholinia, H; Halaji, M; Hosseini, A; Nasrollahian, S; Pournajaf, A; Rajabnia, M; Teimourian, M | 1 |
Dong, L; Feng, J; Geng, H; Gu, S; He, C; Hou, G; Ji, T; Kang, W; Lai, J; Li, Y; Li, Z; Pang, D; Wang, Y; Zhao, L; Zhu, X; Zhu, Y | 1 |
Cao, M; Wang, T; Wei, Q; Zhu, W; Zhu, Y | 1 |
Chacko, S; Maheshwari, TK; Murdeshwar, S; Sheikh, RY | 1 |
Fukasawa, T; Kawakami, K; Okura, T; Takahashi, H; Urushihara, H | 1 |
4 review(s) available for carbapenems and trimethoprim, sulfamethoxazole drug combination
Article | Year |
---|---|
Antibiotic selection in obstetrics: making cost-effective choices.
Topics: Acetamides; Aminoglycosides; Anti-Bacterial Agents; Azithromycin; Carbapenems; Cephalosporins; Clindamycin; Cost-Benefit Analysis; Female; Fluoroquinolones; Humans; Linezolid; Metronidazole; Nitrofurantoin; Oxazolidinones; Penicillins; Pregnancy; Pregnancy Complications, Infectious; Trimethoprim, Sulfamethoxazole Drug Combination | 2002 |
Antibiotics in older adults.
Topics: Age Factors; Aged; Aminoglycosides; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Infective Agents, Urinary; beta-Lactamase Inhibitors; Carbapenems; Cephalosporins; Drug Interactions; Fluoroquinolones; Humans; Macrolides; Monobactams; Penicillins; Trimethoprim, Sulfamethoxazole Drug Combination | 2004 |
Combination therapy for Gram-negative bacteria: what is the evidence?
Topics: Anti-Bacterial Agents; Carbapenems; Clinical Trials as Topic; Drug Resistance, Multiple, Bacterial; Drug Synergism; Drug Therapy, Combination; Fluoroquinolones; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Minocycline; Polymyxins; Tigecycline; Trimethoprim, Sulfamethoxazole Drug Combination | 2013 |
Nocardiosis in patients with nephrotic syndrome: a retrospective analysis of 11 cases and a literature review.
Topics: Abscess; Adult; Aged; Anti-Bacterial Agents; C-Reactive Protein; Carbapenems; CD4 Lymphocyte Count; Drug Therapy, Combination; Female; Fever; Glucocorticoids; Humans; Lung Diseases; Male; Middle Aged; Nephrotic Syndrome; Nocardia; Nocardia Infections; Pleural Effusion; Procalcitonin; Retrospective Studies; Subcutaneous Tissue; Treatment Outcome; Trimethoprim, Sulfamethoxazole Drug Combination; Young Adult | 2020 |
28 other study(ies) available for carbapenems and trimethoprim, sulfamethoxazole drug combination
Article | Year |
---|---|
Overgrowth of Enterococcus faecium in the feces of patients with hematologic malignancies.
Topics: Aminoglycosides; Ampicillin Resistance; Anti-Bacterial Agents; Bacterial Infections; Carbapenems; Cephalosporins; Colony Count, Microbial; Drug Resistance, Microbial; Enterococcus; Enterococcus faecium; Feces; Hematologic Neoplasms; Humans; Microbial Sensitivity Tests; Nitroimidazoles; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin | 1996 |
[Evaluation of occurrence of Alcaligenes faecalis in clinical samples of patients of the university hospital in Bydgoszcz].
Topics: Alcaligenes faecalis; Carbapenems; Drug Resistance, Bacterial; Environmental Microbiology; Environmental Monitoring; Humans; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Suppuration; Tazobactam; Trimethoprim, Sulfamethoxazole Drug Combination; Urine | 2009 |
Antibiotic exposure as a risk factor for fluconazole-resistant Candida bloodstream infection.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Antifungal Agents; Bacteria; Bacterial Infections; Candida glabrata; Candidemia; Candidiasis; Carbapenems; Clindamycin; Coinfection; Colistin; Drug Resistance, Fungal; Female; Fluconazole; Humans; Israel; Microbial Sensitivity Tests; Middle Aged; Odds Ratio; Prospective Studies; Risk Factors; Trimethoprim, Sulfamethoxazole Drug Combination | 2012 |
The use of doripenem in pediatric cystic fibrosis patients in case of meropenem shortages.
Topics: Adolescent; Anti-Bacterial Agents; Burkholderia cenocepacia; Burkholderia Infections; Carbapenems; Child; Cystic Fibrosis; Disease Progression; Doripenem; Drug Therapy, Combination; Female; Gram-Negative Bacterial Infections; Humans; Infusions, Intravenous; Meropenem; Pseudomonas aeruginosa; Pseudomonas Infections; Pseudomonas stutzeri; Rhodospirillaceae; Thienamycins; Tobramycin; Treatment Outcome; Trimethoprim, Sulfamethoxazole Drug Combination | 2014 |
Nocardiosis: a 15-year experience in a tertiary medical center in Israel.
Topics: Adrenal Cortex Hormones; Adult; Aged; Amikacin; Carbapenems; Ceftriaxone; Cohort Studies; Encephalitis; Female; Humans; Immunocompromised Host; Israel; Male; Middle Aged; Nocardia Infections; Pleuropneumonia; Retrospective Studies; Risk Factors; Skin Diseases, Bacterial; Soft Tissue Infections; Tertiary Care Centers; Treatment Outcome; Trimethoprim, Sulfamethoxazole Drug Combination | 2013 |
First case of disseminated infection with Nocardia cerradoensis in a human.
Topics: Aminoglycosides; Anti-Bacterial Agents; Brain; Carbapenems; Cluster Analysis; DNA Gyrase; DNA, Bacterial; DNA, Ribosomal; Female; Heat-Shock Proteins; Humans; Kidney Transplantation; Microbial Sensitivity Tests; Microscopy; Middle Aged; Molecular Sequence Data; Nocardia; Nocardia Infections; Phylogeny; Radiography, Abdominal; Radiography, Thoracic; RNA, Ribosomal, 16S; Sepsis; Sequence Analysis, DNA; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Transplant Recipients; Treatment Outcome; Trimethoprim, Sulfamethoxazole Drug Combination | 2015 |
Secular trends in Acinetobacter baumannii resistance in respiratory and blood stream specimens in the United States, 2003 to 2012: A survey study.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Ampicillin; Anti-Bacterial Agents; Bacteremia; Carbapenems; Cross Infection; Drug Resistance, Bacterial; Humans; Intensive Care Units; Microbial Sensitivity Tests; Respiratory Tract Infections; Sulbactam; Surveys and Questionnaires; Trimethoprim, Sulfamethoxazole Drug Combination; United States | 2016 |
Successful Treatment of Carbapenemase-Producing Pandrug-Resistant Klebsiella pneumoniae Bacteremia.
Topics: Anti-Bacterial Agents; Antiviral Agents; Azabicyclo Compounds; Bacteremia; Bacterial Proteins; beta-Lactamases; Carbapenems; Ceftazidime; Colectomy; Colistin; Drug Combinations; Drug Resistance, Multiple, Bacterial; Female; Ganciclovir; Humans; Immunosuppressive Agents; Intestine, Small; Klebsiella Infections; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests; Middle Aged; Minocycline; Thienamycins; Tigecycline; Trimethoprim, Sulfamethoxazole Drug Combination; Valganciclovir | 2015 |
Low Prevalence of Carbapenem-Resistant Bacteria in River Water: Resistance Is Mostly Related to Intrinsic Mechanisms.
Topics: Aeromonas; Aminoglycosides; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Chloramphenicol; Chromobacterium; Enterobacteriaceae; Environmental Monitoring; Gene Expression; Microbial Sensitivity Tests; Plasmids; Portugal; Pseudomonas; Quinolones; Rivers; Shewanella; Stenotrophomonas maltophilia; Trimethoprim, Sulfamethoxazole Drug Combination; Water Microbiology | 2015 |
Antibiotic Resistance Profiles and Genetic Similarities Within a New Generation of Carbapenem-Resistant Acinetobacter calcoaceticus-A. baumannii Complex Resistotypes in Bosnia and Herzegovina.
Topics: Acinetobacter baumannii; Acinetobacter calcoaceticus; Acinetobacter Infections; Aminoglycosides; Anti-Bacterial Agents; Bacterial Typing Techniques; beta-Lactam Resistance; Bosnia and Herzegovina; Carbapenems; Clone Cells; Cross Infection; Drug Resistance, Multiple, Bacterial; Humans; Phylogeny; Trimethoprim, Sulfamethoxazole Drug Combination | 2016 |
Bacteremia due to carbapenem-resistant Enterobacteriaceae in neutropenic patients with hematologic malignancies.
Topics: Adult; Anti-Bacterial Agents; Bacteremia; beta-Lactam Resistance; Carbapenems; Case-Control Studies; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Hematologic Neoplasms; Humans; Male; Middle Aged; Neutropenia; New York City; Prevalence; Risk Factors; Trimethoprim, Sulfamethoxazole Drug Combination; Young Adult | 2016 |
In Vitro Bactericidal Activity of Trimethoprim-Sulfamethoxazole Alone and in Combination with Colistin against Carbapenem-Resistant Acinetobacter baumannii Clinical Isolates.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Carbapenems; Colistin; Drug Resistance, Multiple, Bacterial; Drug Synergism; Humans; Microbial Sensitivity Tests; Trimethoprim, Sulfamethoxazole Drug Combination | 2016 |
Clinical predictors of Stenotrophomonas maltophilia bacteremia in adult patients with hematologic malignancy.
Topics: Adult; Aged; Anti-Bacterial Agents; Carbapenems; Case-Control Studies; Cross Infection; Female; Gram-Negative Bacterial Infections; Hematologic Neoplasms; Humans; Immunocompromised Host; Male; Middle Aged; Multivariate Analysis; Pneumonia; Prognosis; Stenotrophomonas maltophilia; Survival Analysis; Tertiary Care Centers; Trimethoprim, Sulfamethoxazole Drug Combination | 2018 |
Carbapenem non-susceptibility of
Topics: Adult; Anti-Bacterial Agents; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Colistin; Cross Infection; Drug Resistance, Multiple, Bacterial; Female; Gentamicins; Germany; Hospitals; Humans; Intensive Care Units; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Tertiary Care Centers; Tigecycline; Trimethoprim, Sulfamethoxazole Drug Combination; Young Adult | 2018 |
In Vitro Bactericidal Activity of Trimethoprim-Sulfamethoxazole/Colistin Combination Against Carbapenem-Resistant Klebsiella pneumoniae Clinical Isolates.
Topics: Anti-Bacterial Agents; Carbapenems; China; Colistin; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Molecular Epidemiology; Trimethoprim, Sulfamethoxazole Drug Combination | 2019 |
Identification and Characterization of IncA/C Conjugative,
Topics: Animals; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cephalosporins; Conjugation, Genetic; Drug Resistance, Multiple, Bacterial; Gene Expression; Humans; Microbial Sensitivity Tests; Penaeidae; Plasmids; Seafood; Sequence Analysis, DNA; Trimethoprim, Sulfamethoxazole Drug Combination; Vibrio alginolyticus | 2018 |
Manifestations and outcomes of nocardia infections: Comparison of immunocompromised and nonimmunocompromised adult patients.
Topics: Adult; Aged; Anti-Bacterial Agents; Carbapenems; Drug Therapy, Combination; Eye Infections, Bacterial; Female; Humans; Immunocompromised Host; Lung Diseases; Male; Middle Aged; Nocardia; Nocardia Infections; Retrospective Studies; Risk Factors; Transplantation; Trimethoprim, Sulfamethoxazole Drug Combination | 2018 |
In vivo activity of co-trimoxazole combined with colistin against Acinetobacter baumannii producing OXA-23 in a Galleria mellonella model.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Animals; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Colistin; Disease Models, Animal; Drug Resistance, Multiple, Bacterial; Drug Synergism; Drug Therapy, Combination; Humans; Lepidoptera; Microbial Sensitivity Tests; Trimethoprim, Sulfamethoxazole Drug Combination | 2019 |
Trimethoprim-sulfamethoxazole vs. colistin or ampicillin-sulbactam for the treatment of carbapenem-resistant Acinetobacter baumannii: A retrospective matched cohort study.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Aged; Ampicillin; Anti-Bacterial Agents; Carbapenems; Colistin; Drug Resistance, Multiple, Bacterial; Female; Humans; Male; Middle Aged; Retrospective Studies; Shock, Septic; Sulbactam; Trimethoprim, Sulfamethoxazole Drug Combination | 2019 |
Risk Factors Affecting Patterns of Antibiotic Resistance and Treatment Efficacy in Extreme Drug Resistance in Intensive Care Unit-Acquired Klebsiella Pneumoniae Infections: A 5-Year Analysis.
Topics: Adult; Aged; Anti-Bacterial Agents; Carbapenems; Colistin; Cross Infection; Drug Resistance, Bacterial; Drug Resistance, Microbial; Female; Humans; Intensive Care Units; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Pneumonia; Retrospective Studies; Risk Factors; Survival Rate; Tigecycline; Treatment Outcome; Trimethoprim, Sulfamethoxazole Drug Combination | 2019 |
Uropathogens and antibiotic resistance in the community and hospital-induced urinary tract infected children.
Topics: Adolescent; Amikacin; Ampicillin; Anti-Bacterial Agents; Carbapenems; Child; Child, Preschool; Drug Resistance, Bacterial; Escherichia coli; Female; Humans; Infant; Infant, Newborn; Inpatients; Klebsiella; Male; Microbial Sensitivity Tests; Outpatients; Proteus; Retrospective Studies; Trimethoprim, Sulfamethoxazole Drug Combination; Turkey; Urinary Tract Infections | 2020 |
Characteristics of Stenotrophomonas maltophilia infection in children in Sichuan, China, from 2010 to 2017.
Topics: Age Distribution; Anti-Bacterial Agents; Carbapenems; Ceftazidime; Child, Preschool; China; Clavulanic Acids; Comorbidity; Female; Gram-Negative Bacterial Infections; Hospitalization; Humans; Immunosuppressive Agents; Infant; Intensive Care Units, Pediatric; Length of Stay; Male; Piperacillin, Tazobactam Drug Combination; Respiration, Artificial; Retrospective Studies; Risk Factors; Sex Distribution; Stenotrophomonas maltophilia; Surgical Procedures, Operative; Ticarcillin; Trimethoprim, Sulfamethoxazole Drug Combination | 2020 |
High-risk lineages among extended-spectrum β-lactamase-producing Escherichia coli from extraintestinal infections in Maputo Central Hospital, Mozambique.
Topics: Amoxicillin; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cefotaxime; Ceftazidime; Ciprofloxacin; Clavulanic Acid; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Extraintestinal Pathogenic Escherichia coli; Gentamicins; Hospitals; Humans; Iron; Mozambique; Piperacillin; Tazobactam; Trimethoprim, Sulfamethoxazole Drug Combination | 2022 |
Genetic Diversity, Carbapenem Resistance Genes, and Biofilm Formation in UPEC Isolated from Patients with Catheter-Associated Urinary Tract Infection in North of Iran.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; beta-Lactamases; Biofilms; Carbapenems; Catheters; Cross-Sectional Studies; Edetic Acid; Genetic Variation; Humans; Iran; Nalidixic Acid; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Tract Infections | 2022 |
Drug resistance characteristics and molecular typing of Escherichia coli isolates from neonates in class A tertiary hospitals: A multicentre study across China.
Topics: Anti-Bacterial Agents; Aztreonam; beta-Lactamases; Carbapenems; Cefotaxime; Child; Ciprofloxacin; Doxycycline; Drug Resistance; Escherichia coli; Escherichia coli Infections; Female; Humans; Infant, Newborn; Microbial Sensitivity Tests; Multilocus Sequence Typing; Piperacillin; Pregnancy; Tazobactam; Tertiary Care Centers; Trimethoprim, Sulfamethoxazole Drug Combination | 2022 |
Molecular characterization of class 1 integrons in carbapenem-resistant Enterobacterales isolates.
Topics: Amikacin; Anti-Bacterial Agents; Carbapenems; Integrons; Microbial Sensitivity Tests; Trimethoprim, Sulfamethoxazole Drug Combination | 2023 |
Microbiological Spectrum and Antibiogram of Urinary Tract Infection in a Tertiary Care Center from the Kingdom of Bahrain.
Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Bahrain; beta-Lactamases; Carbapenems; Ciprofloxacin; Escherichia coli; Female; Humans; Klebsiella pneumoniae; Levofloxacin; Male; Microbial Sensitivity Tests; Retrospective Studies; Tertiary Care Centers; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Tract Infections | 2022 |
Risk of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis Associated With Antibiotic Use: A Case-Crossover Study.
Topics: Aminoglycosides; Anti-Bacterial Agents; Carbapenems; Cross-Over Studies; Fosfomycin; Glycopeptides; Humans; Stevens-Johnson Syndrome; Trimethoprim, Sulfamethoxazole Drug Combination | 2023 |